Zhao M, Shao T, Shao H, Zhou C, et al. Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis. BMC Cancer 2024;24:186.
PMID: 38331773